Endpoint Black men (95% CI) White men (95% CI) ...

Gifts in Wills fund one-third of Cancer Research UK’s work; work that supports life-saving trials for people like Alfred.

Currently, abiraterone acetate is being tested in a Phase III trial for men with progressive castration-resistant prostate cancer who are chemotherapy naive. A Phase III trial for patients ...

which may warrant concomitant glucocorticoid replacement with long-term administration of abiraterone acetate. In another Phase I trial, Ryan and colleagues performed a dose-escalation study in 33 ...

Meanwhile, in the active comparator arm, patients will receive abiraterone acetate plus prednisone. In the Phase III MAGNITUDE trial, BRCA-positive patients treated with the combination Akeega ...

Evan Y. Yu, MD, discusses the therapeutic options for metastatic castration-resistant prostate cancer (mCRPC) included in the National Comprehensive Cancer Network (NCCN) guidelines, such as ...

As surgery wouldn’t have been effective, Alfred enrolled in the Cancer Research UK-funded STAMPEDE trial, which tested the drug abiraterone. Alfred responded well to the treatment and his cancer ...

Data from the phase 3 CAPItello-281 trial showed that capivasertib plus abiraterone and androgen deprivation therapy significantly improved radiographic progression-free survival in patients with PTEN ...

Researchers will use a lipidomic biomarker test to select patients with a poor prognosis who may benefit from an investigational combination therapy.

Second interim dividend declared of $2.10 per share, making a total annual dividend declared for FY 2024 of $3.10 per share, an increase of 7%. Di ...

NICE is unable to make a recommendation about the use in the NHS of niraparib with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer in adults. This is ...